News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
8,609 Results
Type
Article (335)
Company Profile (2)
Press Release (8272)
Section
Business (2645)
Career Advice (11)
Deals (422)
Drug Development (407)
FDA (83)
Job Trends (210)
News (3509)
Policy (100)
Tag
Academia (39)
Alliances (1218)
ALS (4)
Alzheimer's disease (43)
Antibody-drug conjugate (ADC) (3)
Approvals (86)
Artificial intelligence (19)
Autoimmune disease (1)
Automation (2)
Bankruptcy (1)
Best Places to Work (199)
Biotechnology (1)
Brain cancer (1)
Breast cancer (9)
Cancer (92)
Cardiovascular disease (7)
Career advice (8)
CAR-T (1)
Cell therapy (4)
Cervical cancer (1)
Clinical research (271)
Collaboration (70)
Compensation (20)
COVID-19 (17)
C-suite (10)
Cystic fibrosis (1)
Data (116)
Diabetes (1)
Diagnostics (191)
Drug discovery (7)
Duchenne muscular dystrophy (1)
Earnings (743)
Events (1233)
Executive appointments (7)
FDA (101)
Frontotemporal dementia (1)
Funding (24)
Generative AI (1)
GLP-1 (5)
Government (12)
Guidances (6)
Healthcare (181)
Huntington's disease (1)
Immunology and inflammation (6)
Immuno-oncology (1)
Indications (1)
Infectious disease (17)
Inflammatory bowel disease (3)
Intellectual property (1)
Interviews (4)
IPO (139)
Job creations (17)
Job search strategy (7)
Legal (21)
Liver cancer (3)
Longevity (1)
Lung cancer (12)
Lymphoma (1)
Machine learning (3)
Manufacturing (2)
Medical device (57)
Medtech (57)
Mergers & acquisitions (296)
Metabolic disorders (3)
Multiple sclerosis (5)
Neurodegenerative disease (24)
Neuroscience (71)
NextGen: Class of 2026 (55)
Non-profit (21)
Now hiring (2)
Obesity (1)
Opinion (2)
Ovarian cancer (1)
Pancreatic cancer (3)
Parkinson's disease (7)
Patents (2)
Patient recruitment (3)
People (663)
Pharmaceutical (1)
Phase 1 (88)
Phase 2 (156)
Phase 3 (75)
Pipeline (75)
Postmarket research (5)
Preclinical (103)
Press Release (1)
Prostate cancer (2)
Radiopharmaceuticals (1)
Rare diseases (7)
Real estate (72)
Regulatory (84)
Reports (2)
Research institute (46)
Series A (10)
Series B (3)
Sickle cell disease (1)
Sponsored (1)
Startups (54)
Vaccines (3)
Venture capital (1)
Women's health (1)
Date
Last 7 days (10)
Last 30 days (30)
Last 365 days (441)
2026 (45)
2025 (450)
2024 (551)
2023 (594)
2022 (956)
2021 (811)
2020 (551)
2019 (443)
2018 (298)
2017 (337)
2016 (351)
2015 (395)
2014 (227)
2013 (196)
2012 (286)
2011 (314)
2010 (330)
Location
Africa (12)
Alabama (5)
Arizona (1)
Arkansas (1)
Asia (283)
Australia (60)
California (210)
Canada (17)
China (2)
Colorado (14)
Connecticut (48)
Delaware (3)
Europe (1620)
Florida (10)
Georgia (1)
Idaho (1)
Illinois (5)
India (1)
Japan (5)
Maine (1)
Maryland (12)
Massachusetts (165)
Michigan (2)
Minnesota (4)
Missouri (3)
Montana (1)
Nebraska (1)
New Jersey (13)
New York (28)
North Carolina (20)
Northern California (132)
Ohio (3)
Oregon (3)
Pennsylvania (18)
South America (5)
South Carolina (2)
Southern California (55)
Texas (16)
United States (597)
Virginia (1)
Washington State (26)
Wisconsin (3)
8,609 Results for "mrm proteomics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis
January 9, 2026
·
3 min read
Press Releases
Enthorin Therapeutics Announces Initiation of Phase II Clinical Trial of MRM-3379 (Formerly ENT-3379) for Fragile X Syndrome by Licensing Partner Mirum Pharmaceuticals
January 12, 2026
·
2 min read
Press Releases
Mirum Pharmaceuticals Announces First Patient Enrolled in the BLOOM Phase 2 Clinical Study Evaluating MRM-3379 in Fragile X Syndrome
December 2, 2025
·
5 min read
Press Releases
MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline
September 4, 2025
·
6 min read
Press Releases
Evidation Launches Temporal Proteomics Platform to Power Multimodal Autoimmune Research Cohort
January 9, 2026
·
3 min read
Press Releases
UPDATE – PrognomiQ Launches ProVue Lung, a Proteomics-Based Laboratory Developed Test to Aid in the Early Detection of Lung Cancer
November 19, 2025
·
3 min read
Press Releases
Enodia Therapeutics Secures €20.7M to Advance a Small-Molecule Platform for Targeted Protein Degradation Enabled by Proteomics and Machine Learning
January 9, 2026
·
6 min read
Press Releases
Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay
January 8, 2026
·
6 min read
Press Releases
Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson’s Disease
January 29, 2026
·
7 min read
Press Releases
Astrin Biosciences Announces Scientific Advisory Board to Advance Early Cancer Detection Leveraging AI and Proteomics
December 8, 2025
·
3 min read
1 of 861
Next
